For the eleventh year running, Endocrine News talks to editors from Endocrine Society publications to unearth the most impressive breakthroughs in endocrine science and research for 2025. From GLP-1s, adrenal treatments, and acromegaly breakthroughs to obesity, diabetes, and cutting-edge research in reproductive medicine, 2025 was a banner year for endocrine research and researchers! For more...
Women with persistent thyroid hormone imbalance across pregnancy may be at an increased risk of having children with autism, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Maternal thyroid hormones are essential for fetal neurodevelopment. Gestational thyroid imbalance has been associated with atypical neurodevelopment, including increased risk of autism spectrum disorder (ASD). Autism is...
For patients with large, symptomatic thyroid goiters and toxic nodules, the question of whether to undergo surgery may soon have a less invasive answer. A new procedure, pressure-enabled thyroid embolization (PED-TAE), is emerging as a promising alternative. An initial clinical study published in the Journal of the Endocrine Society titled, “Safety and Efficacy of Pressure-Enabled...
Approved a little more than a year ago by the U.S. Food and Drug Administration, palopegteriparatide was lauded by a panel of experts from around the world in a recently published consensus statement on hypoparathyroidism treatment. Aliya Khan, MD, talks to Endocrine News what this means for these patients’ treatment options, quality of life, and...
For decades, scientists have known that thyroid hormones play a pivotal role in regulating heart rate and other cardiovascular functions. An overactive thyroid, for example, can cause the heart to race, while an underactive one can slow it down. However, new research is revealing that this relationship is far more complex than previously understood, challenging...
A recent study entitled “Association Between Per- and Polyfluoroalkyl Substance Exposures and Thyroid Homeostasis Parameters,” published in the Journal of Clinical Endocrinology & Metabolism, has found that exposure to per- and polyfluoroalkyl substances (PFAS) — a group of synthetic chemicals used in industrial and consumer products — may alter thyroid hormone sensitivity, potentially affecting metabolism...
Elizabeth Pearce, MD, MSc, discusses her ENDO 2024 presentation, which found that exposure to some endocrine-disrupting chemicals that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and pregnant women, especially among those with lower social and economic status. Elizabeth Pearce, MD, MSc, of the Boston University...
Exposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and pregnant women, especially among those with lower social and economic status, according to a study presented at ENDO 2024. The researchers focused this study on women who may be particularly...
Endocrine News provides the latest news and research articles on thyroid conditions and treatment. For more info read this month’s issue of Endocrine News.
For the eleventh year running, Endocrine News talks to editors from Endocrine Society publications to unearth the most impressive breakthroughs in endocrine science and research for 2025. From GLP-1s, adrenal treatments, and acromegaly breakthroughs to obesity, diabetes, and cutting-edge research in reproductive medicine, 2025 was a banner year for endocrine research and researchers! For more...
For patients with large, symptomatic thyroid goiters and toxic nodules, the question of whether to undergo surgery may soon have a less invasive answer. A new procedure, pressure-enabled thyroid embolization (PED-TAE), is emerging as a promising alternative. An initial clinical study published in the Journal of the Endocrine Society titled, “Safety and Efficacy of Pressure-Enabled...
